{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T11:12:05Z","timestamp":1777979525199,"version":"3.51.4"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,5,5]]},"DOI":"10.7759\/cureus.108286","type":"journal-article","created":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T10:25:15Z","timestamp":1777976715000},"source":"Crossref","is-referenced-by-count":0,"title":["Bleeding Risk Assessment and Management Strategies for Elective Surgery and Invasive Procedures: A Systematic Review"],"prefix":"10.7759","author":[{"given":"Hasan","family":"Alsagga","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammed I","family":"Bassiony","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Osman M. B.","family":"Eladani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bara","family":"Elhadi Elmana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zinat","family":"Alagha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yumna","family":"Suliman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hatim","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmed Elsir","family":"Mokhtar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Asim","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra040403","article-title":"Treatment of von Willebrand's disease","volume":"351","author":"Mannucci PM","year":"2004","unstructured":"Mannucci PM. Treatment of von Willebrand's disease. N Engl J Med. 2004, 351:683-94. 10.1056\/NEJMra040403","journal-title":"N Engl J Med"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2005.01204.x","article-title":"Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients","volume":"3","author":"Schulman S","year":"2005","unstructured":"Schulman S, Kearon C. Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients. J Thromb Haemost. 2005, 3:692-4. 10.1111\/j.1538-7836.2005.01204.x","journal-title":"J Thromb Haemost"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2516.2007.01643.x","article-title":"von Willebrand disease (VWD): evidence-based diagnosis and management guidelines, the National Heart, Lung, and Blood Institute (NHLBI) Expert Panel report (USA)","volume":"14","author":"Nichols WL","year":"2008","unstructured":"Nichols WL, Hultin MB, James AH, et al.. von Willebrand disease (VWD): evidence-based diagnosis and management guidelines, the National Heart, Lung, and Blood Institute (NHLBI) Expert Panel report (USA). Haemophilia. 2008, 14:171-232. 10.1111\/j.1365-2516.2007.01643.x","journal-title":"Haemophilia"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2010.03975.x","article-title":"ISTH\/SSC bleeding assessment tool: a standardized questionnaire and a proposal for a new bleeding score for inherited bleeding disorders","volume":"8","author":"Rodeghiero F","year":"2010","unstructured":"Rodeghiero F, Tosetto A, Abshire T, et al.. ISTH\/SSC bleeding assessment tool: a standardized questionnaire and a proposal for a new bleeding score for inherited bleeding disorders. J Thromb Haemost. 2010, 8:2063-5. 10.1111\/j.1538-7836.2010.03975.x","journal-title":"J Thromb Haemost"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(10)60835-5","article-title":"Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH- 2): a randomised, placebo-controlled trial","volume":"376","author":"Shakur H","year":"2010","unstructured":"Shakur H, Roberts I, Bautista R, et al.. Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH- 2): a randomised, placebo-controlled trial. Lancet. 2010, 376:23-32. 10.1016\/S0140-6736(10)60835-5","journal-title":"Lancet"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.e3054","article-title":"Effect of tranexamic acid on surgical bleeding: systematic review and cumulative meta-analysis","volume":"344","author":"Ker K","year":"2012","unstructured":"Ker K, Edwards P, Perel P, Shakur H, Roberts I. Effect of tranexamic acid on surgical bleeding: systematic review and cumulative meta-analysis. BMJ. 2012, 344:e3054. 10.1136\/bmj.e3054","journal-title":"BMJ"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1111\/hae.12503","article-title":"Normal range of bleeding scores for the ISTH-BAT: adult and pediatric data from the merging project","volume":"20","author":"Elbatarny M","year":"2014","unstructured":"Elbatarny M, Mollah S, Grabell J, et al.. Normal range of bleeding scores for the ISTH-BAT: adult and pediatric data from the merging project. Haemophilia. 2014, 20:831-5. 10.1111\/hae.12503","journal-title":"Haemophilia"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1111\/jth.13140","article-title":"Definition of clinically relevant non-major bleeding in studies of anticoagulants in atrial fibrillation and venous thromboembolic disease in non-surgical patients: communication from the SSC of the ISTH","volume":"13","author":"Kaatz S","year":"2015","unstructured":"Kaatz S, Ahmad D, Spyropoulos AC, Schulman S. Definition of clinically relevant non-major bleeding in studies of anticoagulants in atrial fibrillation and venous thromboembolic disease in non-surgical patients: communication from the SSC of the ISTH. J Thromb Haemost. 2015, 13:2119-26. 10.1111\/jth.13140","journal-title":"J Thromb Haemost"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1601561","article-title":"Von Willebrand's disease","volume":"375","author":"Leebeek FW","year":"2016","unstructured":"Leebeek FW, Eikenboom JC. Von Willebrand's disease. N Engl J Med. 2016, 375:2067-80. 10.1056\/NEJMra1601561","journal-title":"N Engl J Med"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1111\/hae.14046","article-title":"WFH guidelines for the management of hemophilia","volume":"26 Suppl 6","author":"Srivastava A","year":"2020","unstructured":"Srivastava A, Santagostino E, Dougall A, et al.. WFH guidelines for the management of hemophilia. Haemophilia. 2020, 26 Suppl 6:1-158. 10.1111\/hae.14046","journal-title":"Haemophilia"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2020002038","article-title":"Low VWF: insights into pathogenesis, diagnosis, and clinical management","volume":"4","author":"O'Donnell JS","year":"2020","unstructured":"O'Donnell JS. Low VWF: insights into pathogenesis, diagnosis, and clinical management. Blood Adv. 2020, 4:3191-9. 10.1182\/bloodadvances.2020002038","journal-title":"Blood Adv"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2020003265","article-title":"ASH ISTH NHF WFH 2021 guidelines on the diagnosis of von Willebrand disease","volume":"5","author":"James PD","year":"2021","unstructured":"James PD, Connell NT, Ameer B, et al.. ASH ISTH NHF WFH 2021 guidelines on the diagnosis of von Willebrand disease. Blood Adv. 2021, 5:280-300. 10.1182\/bloodadvances.2020003265","journal-title":"Blood Adv"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2020003264","article-title":"ASH ISTH NHF WFH 2021 guidelines on the management of von Willebrand disease","volume":"5","author":"Connell NT","year":"2021","unstructured":"Connell NT, Flood VH, Brignardello-Petersen R, et al.. ASH ISTH NHF WFH 2021 guidelines on the management of von Willebrand disease. Blood Adv. 2021, 5:301-25. 10.1182\/bloodadvances.2020003264","journal-title":"Blood Adv"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtha.2024.03.005","article-title":"Standardization of definition and management for bleeding disorder of unknown cause: communication from the SSC of the ISTH","volume":"22","author":"Baker RI","year":"2024","unstructured":"Baker RI, Choi P, Curry N, et al.. Standardization of definition and management for bleeding disorder of unknown cause: communication from the SSC of the ISTH. J Thromb Haemost. 2024, 22:2059-70. 10.1016\/j.jtha.2024.03.005","journal-title":"J Thromb Haemost"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page MJ","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, et al.. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021, 372:n71. 10.1136\/bmj.n71","journal-title":"BMJ"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1136\/emermed-2020-209567","article-title":"Population, Intervention, Comparison, Outcomes and Study (PICOS) design as a framework to formulate eligibility criteria in systematic reviews","volume":"37","author":"Amir-Behghadami M","year":"2020","unstructured":"Amir-Behghadami M, Janati A. Population, Intervention, Comparison, Outcomes and Study (PICOS) design as a framework to formulate eligibility criteria in systematic reviews. Emerg Med J. 2020, 37:387. 10.1136\/emermed-2020-209567","journal-title":"Emerg Med J"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1111\/hae.14376","article-title":"Preoperative bleeding risk assessment with ISTH-BAT and laboratory tests in patients undergoing elective surgery: a prospective cohort study","volume":"27","author":"Ambaglio C","year":"2021","unstructured":"Ambaglio C, Zane F, Russo MC, et al.. Preoperative bleeding risk assessment with ISTH-BAT and laboratory tests in patients undergoing elective surgery: a prospective cohort study. Haemophilia. 2021, 27:717-23. 10.1111\/hae.14376","journal-title":"Haemophilia"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1111\/hae.14365","article-title":"Elective surgery in patients with inherited bleeding disorders: a retrospective analysis","volume":"27","author":"Clarke L","year":"2021","unstructured":"Clarke L, Dennington PM, Curnow J. Elective surgery in patients with inherited bleeding disorders: a retrospective analysis. Haemophilia. 2021, 27:744-50. 10.1111\/hae.14365","journal-title":"Haemophilia"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1111\/hae.13691","article-title":"Low endoscopy bleeding risk in patients with congenital bleeding disorders","volume":"25","author":"Tomaszewski M","year":"2019","unstructured":"Tomaszewski M, Bienz M, Kherad O, et al.. Low endoscopy bleeding risk in patients with congenital bleeding disorders. Haemophilia. 2019, 25:289-95. 10.1111\/hae.13691","journal-title":"Haemophilia"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1111\/hae.13954","article-title":"Hemostatic prophylaxis and colonoscopy outcomes for patients with bleeding disorders: a retrospective cohort study and review of the literature","volume":"26","author":"Azer SM","year":"2020","unstructured":"Azer SM, Eckerman AL, Rodriguez V, et al.. Hemostatic prophylaxis and colonoscopy outcomes for patients with bleeding disorders: a retrospective cohort study and review of the literature. Haemophilia. 2020, 26:257-68. 10.1111\/hae.13954","journal-title":"Haemophilia"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1111\/hae.15055","article-title":"Oral surgery in people with inherited bleeding disorder: a retrospective study","volume":"30","author":"Fribourg E","year":"2024","unstructured":"Fribourg E, Castet S, F\u00e9nelon M, Huguenin Y, Fricain JC, Chuy V, Catros S. Oral surgery in people with inherited bleeding disorder: a retrospective study. Haemophilia. 2024, 30:943-9. 10.1111\/hae.15055","journal-title":"Haemophilia"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1111\/hae.12782","article-title":"Replacement therapy in inherited factor VII deficiency: occurrence of adverse events and relation with surgery","volume":"21","author":"Napolitano M","year":"2015","unstructured":"Napolitano M, Dolce A, Batorova A, et al.. Replacement therapy in inherited factor VII deficiency: occurrence of adverse events and relation with surgery. Haemophilia. 2015, 21:e513-7. 10.1111\/hae.12782","journal-title":"Haemophilia"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1111\/hae.12811","article-title":"Unclassified bleeding disorders: outcome of haemostatic challenges following tranexamic acid and\/or desmopressin","volume":"22","author":"Obaji S","year":"2016","unstructured":"Obaji S, Alikhan R, Rayment R, Carter P, Macartney N, Collins P. Unclassified bleeding disorders: outcome of haemostatic challenges following tranexamic acid and\/or desmopressin. Haemophilia. 2016, 22:285-91. 10.1111\/hae.12811","journal-title":"Haemophilia"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1111\/jth.15220","article-title":"Management of elective procedures in low von Willebrand factor patients in the LoVIC study","volume":"19","author":"Doherty D","year":"2021","unstructured":"Doherty D, Lavin M, O'Sullivan JM, et al.. Management of elective procedures in low von Willebrand factor patients in the LoVIC study. J Thromb Haemost. 2021, 19:701-10. 10.1111\/jth.15220","journal-title":"J Thromb Haemost"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1055\/s-0041-1726344","article-title":"Outcome of surgical interventions and deliveries in patients with bleeding of unknown cause: an observational study","volume":"121","author":"Veen CS","year":"2021","unstructured":"Veen CS, Huisman EJ, Romano LG, et al.. Outcome of surgical interventions and deliveries in patients with bleeding of unknown cause: an observational study. Thromb Haemost. 2021, 121:1409-16. 10.1055\/s-0041-1726344","journal-title":"Thromb Haemost"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1016\/j.rpth.2023.102199","article-title":"Surgery in rare bleeding disorders: the prospective MARACHI study","volume":"7","author":"Rousseau F","year":"2023","unstructured":"Rousseau F, Guillet B, Mura T, et al.. Surgery in rare bleeding disorders: the prospective MARACHI study. Res Pract Thromb Haemost. 2023, 7:102199. 10.1016\/j.rpth.2023.102199","journal-title":"Res Pract Thromb Haemost"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1111\/jth.14313","article-title":"Phase 3 study of recombinant von Willebrand factor in patients with severe von Willebrand disease who are undergoing elective surgery","volume":"17","author":"Peyvandi F","year":"2019","unstructured":"Peyvandi F, Mamaev A, Wang JD, et al.. Phase 3 study of recombinant von Willebrand factor in patients with severe von Willebrand disease who are undergoing elective surgery. J Thromb Haemost. 2019, 17:52-62. 10.1111\/jth.14313","journal-title":"J Thromb Haemost"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1111\/hae.13451","article-title":"Analysis of current perioperative management with Haemate(\u00ae) P\/Humate P(\u00ae) in von Willebrand disease: Identifying the need for personalized treatment","volume":"24","author":"Hazendonk HC","year":"2018","unstructured":"Hazendonk HC, Heijdra JM, de Jager NC, et al.. Analysis of current perioperative management with Haemate(\u00ae) P\/Humate P(\u00ae) in von Willebrand disease: Identifying the need for personalized treatment. Haemophilia. 2018, 24:460-70. 10.1111\/hae.13451","journal-title":"Haemophilia"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2516.1998.0040s3033.x","article-title":"Pharmacokinetics, efficacy and safety of Humate-P in von Willebrand disease","volume":"4 Suppl 3","author":"Dobrkovska A","year":"1998","unstructured":"Dobrkovska A, Krzensk U, Chediak JR. Pharmacokinetics, efficacy and safety of Humate-P in von Willebrand disease. Haemophilia. 1998, 4 Suppl 3:33-9. 10.1046\/j.1365-2516.1998.0040s3033.x","journal-title":"Haemophilia"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1111\/jth.14652","article-title":"One piece of the puzzle: population pharmacokinetics of FVIII during perioperative Haemate P(\u00ae) \/Humate P(\u00ae) treatment in von Willebrand disease patients","volume":"18","author":"de Jager NC","year":"2020","unstructured":"de Jager NC, Bukkems LH, Heijdra JM, et al.. One piece of the puzzle: population pharmacokinetics of FVIII during perioperative Haemate P(\u00ae) \/Humate P(\u00ae) treatment in von Willebrand disease patients. J Thromb Haemost. 2020, 18:295-305. 10.1111\/jth.14652","journal-title":"J Thromb Haemost"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1016\/j.thromres.2014.12.017","article-title":"Clinical use of Haemate\u00ae P in von Willebrand disease: a 25-year retrospective observational study","volume":"135","author":"Miesbach W","year":"2015","unstructured":"Miesbach W, Krekeler S, Wolf Z, Seifried E. Clinical use of Haemate\u00ae P in von Willebrand disease: a 25-year retrospective observational study. Thromb Res. 2015, 135:479-84. 10.1016\/j.thromres.2014.12.017","journal-title":"Thromb Res"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.20452\/pamw.4298","article-title":"Dental extractions in patients with mild hemophilia A and hemophilia B and von Willebrand disease without clotting factor supplementation","volume":"128","author":"Lewandowski B","year":"2018","unstructured":"Lewandowski B, Wojnar J, Brodowski R, Mucha M, Czenczek-Lewandowska E, Brz\u0119cka D. Dental extractions in patients with mild hemophilia A and hemophilia B and von Willebrand disease without clotting factor supplementation. Pol Arch Intern Med. 2018, 128:488-90. 10.20452\/pamw.4298","journal-title":"Pol Arch Intern Med"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1016\/S0030-4220(06)80099-X","article-title":"Evaluation of desmopressin for dental extractions in patients with hemostatic disorders","volume":"77","author":"Saulnier J","year":"1994","unstructured":"Saulnier J, Marey A, Horellou MH, et al.. Evaluation of desmopressin for dental extractions in patients with hemostatic disorders. Oral Surg Oral Med Oral Pathol. 1994, 77:6-12. 10.1016\/S0030-4220(06)80099-X","journal-title":"Oral Surg Oral Med Oral Pathol"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.2.5809.311","article-title":"Tranexamic acid in control of haemorrhage after dental extraction in haemophilia and Christmas disease","volume":"2","author":"Forbes CD","year":"1972","unstructured":"Forbes CD, Barr RD, Reid G, Thomson C, Prentice CR, McNicol GP, Douglas AS. Tranexamic acid in control of haemorrhage after dental extraction in haemophilia and Christmas disease. Br Med J. 1972, 2:311-3. 10.1136\/bmj.2.5809.311","journal-title":"Br Med J"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.4103\/0976-237X.128663","article-title":"Efficacy of tranexamic acid mouthwash as an alternative for factor replacement in gingival bleeding during dental scaling in cases of hemophilia: a randomized clinical trial","volume":"5","author":"Nuvvula S","year":"2014","unstructured":"Nuvvula S, Gaddam KR, Kamatham R. Efficacy of tranexamic acid mouthwash as an alternative for factor replacement in gingival bleeding during dental scaling in cases of hemophilia: a randomized clinical trial. Contemp Clin Dent. 2014, 5:49-53. 10.4103\/0976-237X.128663","journal-title":"Contemp Clin Dent"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1111\/jth.14928","article-title":"Management of von Willebrand disease with a factor VIII-poor von Willebrand factor concentrate: results from a prospective observational post-marketing study","volume":"18","author":"Goudemand J","year":"2020","unstructured":"Goudemand J, Bridey F, Claeyssens S, et al.. Management of von Willebrand disease with a factor VIII-poor von Willebrand factor concentrate: results from a prospective observational post-marketing study. J Thromb Haemost. 2020, 18:1922-33. 10.1111\/jth.14928","journal-title":"J Thromb Haemost"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2516.2011.02534.x","article-title":"von Willebrand factor\/factor VIII concentrate (Humate-P) for management of elective surgery in adults and children with von Willebrand disease","volume":"17","author":"Gill JC","year":"2011","unstructured":"Gill JC, Shapiro A, Valentino LA, Bernstein J, Friedman C, Nichols WL, Manco-Johnson M. von Willebrand factor\/factor VIII concentrate (Humate-P) for management of elective surgery in adults and children with von Willebrand disease. Haemophilia. 2011, 17:895-905. 10.1111\/j.1365-2516.2011.02534.x","journal-title":"Haemophilia"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1111\/hae.13718","article-title":"Periprocedural management of von Willebrand disease: an institutional experience","volume":"25","author":"Seaman CD","year":"2019","unstructured":"Seaman CD, Ragni MV. Periprocedural management of von Willebrand disease: an institutional experience. Haemophilia. 2019, 25:e199-203. 10.1111\/hae.13718","journal-title":"Haemophilia"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.15055","article-title":"Role of clinical and laboratory parameters for treatment choice in patients with inherited FVII deficiency undergoing surgical procedures: evidence from the STER registry","volume":"180","author":"Di Minno MN","year":"2018","unstructured":"Di Minno MN, Napolitano M, Dolce A, Mariani G. Role of clinical and laboratory parameters for treatment choice in patients with inherited FVII deficiency undergoing surgical procedures: evidence from the STER registry. Br J Haematol. 2018, 180:563-70. 10.1111\/bjh.15055","journal-title":"Br J Haematol"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2010.08287.x","article-title":"Recombinant, activated factor VII for surgery in factor VII deficiency: a prospective evaluation - the surgical STER","volume":"152","author":"Mariani G","year":"2011","unstructured":"Mariani G, Dolce A, Batorova A, et al.. Recombinant, activated factor VII for surgery in factor VII deficiency: a prospective evaluation - the surgical STER. Br J Haematol. 2011, 152:340-6. 10.1111\/j.1365-2141.2010.08287.x","journal-title":"Br J Haematol"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1016\/j.rpth.2024.102572","article-title":"Periprocedural hemostatic prophylaxis and outcomes in bleeding disorder of unknown cause","volume":"8","author":"Berkowitz C","year":"2024","unstructured":"Berkowitz C, Ma A, Miller V, et al.. Periprocedural hemostatic prophylaxis and outcomes in bleeding disorder of unknown cause. Res Pract Thromb Haemost. 2024, 8:102572. 10.1016\/j.rpth.2024.102572","journal-title":"Res Pract Thromb Haemost"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1177\/10760296231165056","article-title":"Perioperative outcomes of patients with bleeding disorders undergoing major surgery at an academic hemophilia treatment center","volume":"29","author":"Rhoades R","year":"2023","unstructured":"Rhoades R, French Z, Yang A, Walsh K, Drelich DA, McKenzie SE. Perioperative outcomes of patients with bleeding disorders undergoing major surgery at an academic hemophilia treatment center. Clin Appl Thromb Hemost. 2023, 29:10760296231165056. 10.1177\/10760296231165056","journal-title":"Clin Appl Thromb Hemost"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1111\/hae.14506","article-title":"Report of surgeries, their outcome and the thrombin generation assay in patients with Factor XI deficiency: a retrospective single-centre study","volume":"28","author":"D\u00e9sage S","year":"2022","unstructured":"D\u00e9sage S, Dargaud Y, Meunier S, et al.. Report of surgeries, their outcome and the thrombin generation assay in patients with Factor XI deficiency: a retrospective single-centre study. Haemophilia. 2022, 28:301-7. 10.1111\/hae.14506","journal-title":"Haemophilia"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/473352-bleeding-risk-assessment-and-management-strategies-for-elective-surgery-and-invasive-procedures-a-systematic-review","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T10:25:16Z","timestamp":1777976716000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/473352-bleeding-risk-assessment-and-management-strategies-for-elective-surgery-and-invasive-procedures-a-systematic-review"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,5]]},"references-count":43,"URL":"https:\/\/doi.org\/10.7759\/cureus.108286","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5,5]]}}}